Yousif Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$393K Sell
8,201
-30,648
-79% -$1.32M ﹤0.01% 1421
2026
Q1
$1.43M Hold
38,849
0.02% 852
2025
Q4
$2.36M Hold
38,849
0.03% 620
2025
Q3
$2.16M Hold
38,849
0.02% 679
2025
Q2
$2.68M Buy
38,849
+2,553
+7% +$174K 0.03% 577
2025
Q1
$2.52M Sell
36,296
-16,500
-31% -$1.36M 0.03% 588
2024
Q4
$4.54M Hold
52,796
0.05% 353
2024
Q3
$6.29M Sell
52,796
-2,347
-4% -$313K 0.07% 269
2024
Q2
$7.87M Sell
55,143
-3,845
-7% -$510K 0.09% 205
2024
Q1
$7.57M Sell
58,988
-1,550
-3% -$185K 0.08% 229
2023
Q4
$6.26M Buy
60,538
+3,900
+7% +$386K 0.07% 260
2023
Q3
$5.15M Sell
56,638
-1,210
-2% -$107K 0.07% 299
2023
Q2
$4.68M Sell
57,848
-646
-1% -$52.8K 0.06% 337
2023
Q1
$4.65M Buy
58,494
+240
+0.4% +$17K 0.06% 326
2022
Q4
$3.94M Hold
58,254
0.05% 402
2022
Q3
$2.9M Buy
58,254
+1,340
+2% +$71.8K 0.04% 497
2022
Q2
$3.17M Buy
56,914
+1,710
+3% +$94.9K 0.04% 501
2022
Q1
$3.06M Hold
55,204
0.03% 616
2021
Q4
$3.09M Buy
+55,204
New +$2.99M 0.03% 652

Other funds holding NVO

Yousif Capital Management's NVO Position: Q2 2026 in Review

Yousif Capital Management reduced its Novo Nordisk (NVO) stake by 79% in Q2 2026, selling an estimated $1.32M and leaving 8,201 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1421.

Yousif Capital Management first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.87M in Q2 2024. 328 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Yousif Capital Management held 8,201 shares of Novo Nordisk worth $393K as of Q2 2026.
  • Yousif Capital Management sold 30,648 Novo Nordisk shares in Q2 2026, an estimated $1.32M.
  • Novo Nordisk made up ﹤0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1421 holding.
  • Yousif Capital Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Novo Nordisk position peaked at $7.87M in Q2 2024.
  • 328 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.